A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® Injection

Clinical trial NCT00463021 · COMPLETED

Trial details

NCT number: NCT00463021
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Secondary Hyperparathyroidism

Start date: 2007-04-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.